PCM
AGN

Prelude Capital Management’s Allergan plc AGN Stock Holding History

Prelude Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-90,626
Closed -$16.1M – 2385
2020
Q1 		$16.1M Sell
90,626
-25,764
-22% -$4.85M 1.08% 10
2019
Q4 		$22.3M Sell
116,390
-88,418
-43% -$16M 0.85% 9
2019
Q3 		$34.5M Buy
204,808
+7,553
+4% +$1.23M 1.55% 5
2019
Q2 		$33M Buy
197,255
+196,435
+23,955% +$27.2M 1.62% 7
2019
Q1 		$120K Buy
820
+578
+239% +$83.8K 0.01% 868
2018
Q4 		$32K Sell
242
-40,740
-99% -$6.68M ﹤0.01% 1191
2018
Q3 		$7.81M Sell
40,982
-25,162
-38% -$4.62M 0.45% 34
2018
Q2 		$11M Buy
66,144
+481
+0.7% +$77.2K 0.7% 23
2018
Q1 		$11.1M Buy
65,663
+73
+0.1% +$12.2K 0.8% 17
2017
Q4 		$10.7M Buy
65,590
+4,129
+7% +$741K 0.86% 19
2017
Q3 		$12.6M Buy
61,461
+10,982
+22% +$2.55M 1.14% 14
2017
Q2 		$12.3M Buy
+50,479
New +$11.9M 1.16% 12
2017
Q1 		– Sell
-462
Closed -$30K – 1897
2016
Q4 		$30K Sell
462
-4,348
-90% -$901K ﹤0.01% 1235
2016
Q3 		$1.11M Sell
4,810
-6,309
-57% -$1.54M 0.12% 193
2016
Q2 		$2.57M Sell
11,119
-7,355
-40% -$1.7M 0.36% 63
2016
Q1 		$4.95M Sell
18,474
-452
-2% -$129K 0.69% 15
2015
Q4 		$5.91M Buy
18,926
+10,481
+124% +$3.12M 0.92% 14
2015
Q3 		$2.29M Sell
8,445
-3,818
-31% -$1.17M 0.33% 58
2015
Q2 		$3.72M Buy
12,263
+850
+7% +$254K 0.52% 29
2015
Q1 		$3.4M Buy
11,413
+8,203
+256% +$2.34M 0.47% 27
2014
Q4 		$826K Buy
3,210
+560
+21% +$140K 0.12% 188
2014
Q3 		$639K Sell
2,650
-4,250
-62% -$951K 0.09% 282
2014
Q2 		$1.54M Buy
6,900
+100
+1% +$20.7K 0.2% 102
2014
Q1 		$1.4M Buy
+6,800
New +$1.35M 0.19% 117

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Prelude Capital Management's AGN Position: Q2 2020 in Review

Prelude Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 90,626 shares — an estimated $16.1M sold.

Prelude Capital Management first reported a position in AGN in Q1 2014 and held it in 24 quarters. The position peaked at $34.5M in Q3 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Prelude Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Prelude Capital Management sold 90,626 Allergan plc shares in Q2 2020, an estimated $16.1M.
  • Prelude Capital Management first reported a position in Allergan plc in Q1 2014 and held it in 24 quarters.
  • Prelude Capital Management's Allergan plc position peaked at $34.5M in Q3 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Prelude Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.